• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

DiabetesWise launches platform for provider decision-making on diabetes devices

April 7, 2022 By Sean Whooley

DiabetesWise

DiabetesWise announced that it launched its DiabetesWise Pro website to help providers make informed decisions on diabetes devices.

Stanford, California–based DiabetesWise says it designed the website as an easy-to-use and free tool for providers to access in the clinical practice or at the point of care. They can identify the best available diabetes device on the market for their patients, followed by the necessary steps for ordering the device based on insurance type.

According to a news release, DiabetesWise Pro includes an extensive device library where providers can learn about FDA-approved diabetes devices on the market and compare devices from different manufacturers through the side-by-side comparison feature. Providers can build a comparison report of the two devices, the details of the technology and the steps for ordering and prescribing. They can then share the reports with patients, colleagues and the community.

The company said another feature, the “prescription tool,” directs the user to a guide providing accurate, up-to-date information on the necessary steps for filing a prescription and ordering the device for the patient.

“DiabetesWise’s mission is to help patients find the right diabetes device for their lifestyle,” the company said in a news release. “The new DiabetesWise Pro website will further advance this important goal. Providers will now have a free, unbiased resource to understand the various technology options available, arming them with the information needed to develop the best-customized care plans for their patients and improve outcomes.”

Filed Under: Auto-injectors, Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring Tagged With: DiabetesWise

IN CASE YOU MISSED IT

  • Elixir Medical reports sustained durability with bioadaptor compared to Medtronic stent
  • Senseonics closes public offering, private placement with Abbott
  • Embecta eyes shift from insulin delivery to broader medical supplies focus
  • Medtronic earns expanded CE mark for Prevail paclitaxel-coated balloon
  • Sequel Med Tech to pair automated insulin delivery system with Abbott’s future dual glucose-ketone sensor

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at swhooley@wtwhmedia.com.

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS